GEOVAX LABS, INC. (GOVX)

Recent Material Events for GEOVAX LABS, INC.
Date Description
Jan 17, 2013 Effective January 17, 2013, the Registrant reduced the exercise price of its outstanding Series B Common Stock Purchase Warrants that were issued in connection with a private placement of its Series A Convertible Preferred Stock that closed on March
Nov 14, 2012 On November 14, 2012 we issued a press release reporting our results of operations for the quarter ended September 30, 2012. A copy of the press release is attached to this Current Report.
Aug 14, 2012 On August 13, 2012 we issued a press release reporting our results of operations for the quarter ended June 30, 2012. A copy of the press release is attached to this Current Report.
Jun 25, 2012 The Company held its annual meeting of the stockholders on June 21, 2012. The Company received proxies totaling approximately 82.2% of its issued and outstanding shares of common stock representing 14,576,400 shares of common stock, as of the record
May 16, 2012 On May 15, 2012 we issued a press release reporting our results of operations for the quarter ended March 31, 2012. A copy of the press release is attached to this Current Report.
Mar 30, 2012 Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer”, “accelerated filer” and &#
Mar 30, 2012 Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer”, “accelerated filer” and &#
Mar 29, 2012 On March 28, 2012 we issued a press release reporting our results of operations for the year ended December 31, 2011. A copy of the press release is attached to this Current Report.
Mar 22, 2012 On March 16, 2012, we entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with the purchasers identified therein (collectively, the “Purchasers”) providing for the issuance and sale to the Purcha
Jan 05, 2012 On December 30, 2011, we sold to fourteen individual accredited investors 658,520 shares of our common stock, $.001 par value, and five-year warrants to purchase an aggregate of 987,783 shares of common stock at an exercise price of $1.00 per share f